HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yiping Wang Selected Research

Epstein-Barr virus encoded RNA 2

1/2022A Polymorphism in the Epstein-Barr Virus EBER2 Noncoding RNA Drives In Vivo Expansion of Latently Infected B Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yiping Wang Research Topics

Disease

30Neoplasms (Cancer)
05/2022 - 06/2008
25Inflammation (Inflammations)
01/2022 - 08/2001
20Fibrosis (Cirrhosis)
01/2021 - 04/2002
16Infections
01/2022 - 06/2008
13Stomach Neoplasms (Stomach Cancer)
06/2021 - 10/2009
12Atherosclerosis
11/2021 - 05/2006
10Chronic Renal Insufficiency
03/2021 - 02/2006
8Proteinuria
01/2022 - 08/2001
8Neoplasm Metastasis (Metastasis)
01/2022 - 01/2014
7Kidney Diseases (Kidney Disease)
01/2019 - 08/2012
7Nephrosis
10/2013 - 01/2005
5Cardiovascular Diseases (Cardiovascular Disease)
05/2022 - 07/2008
5Sclerosis
01/2022 - 10/2003
5Reperfusion Injury
01/2021 - 06/2015
5AIDS-Related Complex (ARC)
04/2020 - 05/2014
5Atrophy
05/2012 - 08/2001
4Glomerulonephritis
01/2022 - 08/2017
4Hyperlipidemias (Hyperlipidemia)
01/2022 - 01/2018
4COVID-19
01/2021 - 12/2020
4Carcinogenesis
12/2020 - 01/2014
4Hypoxia (Hypoxemia)
01/2020 - 01/2005
3Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2022 - 10/2013
3IGA Glomerulonephritis (IGA Nephropathy)
01/2022 - 01/2006
3Disease Resistance
01/2022 - 10/2011
3Nephritis
07/2021 - 01/2013
3Type 2 Diabetes Mellitus (MODY)
05/2021 - 08/2017
3Disease Progression
03/2021 - 01/2017
3Ischemia
01/2021 - 01/2016
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 12/2016
3Pneumonia (Pneumonitis)
01/2021 - 08/2010
3Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
11/2019 - 06/2008
3Ureteral Obstruction
11/2019 - 01/2018
3Enteritis
03/2019 - 01/2017
3Membranous Glomerulonephritis (Membranous Nephropathy)
01/2019 - 01/2013
3Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
09/2018 - 01/2018
3Autoimmune Diseases (Autoimmune Disease)
01/2018 - 02/2006
3Obesity
01/2018 - 01/2012
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2018 - 05/2007
3Communicable Diseases (Infectious Diseases)
07/2016 - 01/2010
3Necrosis
05/2015 - 01/2005
3Leukopenia
04/2013 - 01/2010
2Myocardial Infarction
02/2022 - 04/2010
2Breast Neoplasms (Breast Cancer)
12/2021 - 01/2020
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2021 - 04/2019
2Cysts
01/2021 - 11/2019
2Autosomal Dominant Polycystic Kidney (ADPKD)
01/2021 - 11/2019
2Sepsis (Septicemia)
01/2021 - 09/2013
2Glioma (Gliomas)
12/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

16Doxorubicin (Adriamycin)FDA LinkGeneric
11/2019 - 08/2001
15Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2006
14CytokinesIBA
01/2022 - 01/2005
10DNA (Deoxyribonucleic Acid)IBA
01/2019 - 06/2005
10CreatinineIBA
06/2012 - 08/2001
9Biomarkers (Surrogate Marker)IBA
02/2022 - 04/2016
9Biological ProductsIBA
01/2021 - 09/2013
9VaccinesIBA
01/2021 - 11/2012
9MicroRNAs (MicroRNA)IBA
01/2020 - 03/2011
7Pharmaceutical PreparationsIBA
07/2021 - 05/2006
7CateninsIBA
01/2021 - 01/2016
7Transcription Factors (Transcription Factor)IBA
04/2019 - 01/2009
6Glucose (Dextrose)FDA LinkGeneric
09/2020 - 01/2012
6AntigensIBA
01/2019 - 01/2013
5DNA VaccinesIBA
10/2020 - 02/2006
5Cisplatin (Platino)FDA LinkGeneric
01/2020 - 08/2014
5LipidsIBA
01/2018 - 02/2013
4Therapeutic UsesIBA
03/2021 - 05/2012
4Small Interfering RNA (siRNA)IBA
03/2019 - 08/2014
4NF-kappa B (NF-kB)IBA
01/2018 - 08/2001
41-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
03/2016 - 05/2006
3NucleotidesIBA
01/2022 - 11/2014
3Matrix Metalloproteinases (MMPs)IBA
12/2021 - 03/2010
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021 - 01/2014
3Long Noncoding RNAIBA
12/2020 - 01/2020
3AntioxidantsIBA
07/2020 - 05/2012
3Silicon Dioxide (Silica)FDA LinkGeneric
04/2020 - 05/2014
3Messenger RNA (mRNA)IBA
01/2019 - 01/2014
3Inosine Triphosphate (ITP)IBA
09/2018 - 01/2018
3Reactive Oxygen Species (Oxygen Radicals)IBA
08/2017 - 01/2016
3Indicators and Reagents (Reagents)IBA
11/2014 - 07/2008
3oxidized low density lipoproteinIBA
01/2014 - 04/2010
3Plant ExtractsIBA
04/2013 - 01/2010
3huachansuIBA
04/2013 - 01/2010
2Pattern Recognition ReceptorsIBA
01/2022 - 01/2021
2Pathogen-Associated Molecular Pattern MoleculesIBA
01/2022 - 05/2015
2Interleukin-33IBA
01/2022 - 01/2018
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2021
2Lysine (L-Lysine)FDA Link
06/2021 - 08/2001
2Histones (Histone)IBA
06/2021 - 01/2021
2Polysaccharides (Glycans)IBA
01/2021 - 04/2014
2Cadherins (E-Cadherin)IBA
01/2021 - 01/2016
2Leucine (L-Leucine)FDA Link
01/2021 - 11/2014
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2021 - 01/2017
2ICG 001IBA
01/2021 - 01/2018
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 10/2014
2AntibodiesIBA
12/2020 - 01/2017
2Arginine (L-Arginine)FDA Link
09/2020 - 08/2001

Therapy/Procedure

18Therapeutics
01/2021 - 01/2006
8Drug Therapy (Chemotherapy)
05/2022 - 01/2010
3Remission Induction
04/2013 - 01/2010
2Radiotherapy
05/2022 - 04/2014